Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease Read more
Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg Read more
Zydus gains final USFDA approval for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg Read more